Browsing Department of Family and Community Medicine (MU) by Title "Consider this SGLT2 inhibitor for patients with HF with preserved ejection fraction"
Now showing items 1-1 of 1
-
Consider this SGLT2 inhibitor for patients with HF with preserved ejection fraction
(Family Physicians Inquiries Network, 2022-12)Consider adding empagliflozin 10 mg to usual therapy to reduce hospitalization of symptomatic patients with heart failure with preserved ejection fraction (HFpEF; EF > 40%) and an N-terminal pro–B-type natriuretic peptide ...